Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
OBI Pharma Inc (4174 TT)
Watchlist
6
Analysis
Health Care
•
Taiwan
OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
23 Jul 2024 15:29
Announcement Of The Company’S Board Meeting Date To Approve 2024q2 Consolidated Financial Report
Attachment
Exchange Announcement •
19 Jun 2024 15:05
Announcement On Behalf Of Obigen That The Company’S Board Of Directors Resolved To Appoint Mr. Frank Chen As Chairperson
Attachment
Exchange Announcement •
19 Jun 2024 15:04
Announcement On Behalf Of Obigen Of Resolution To Lift The Non-Competition Restrictions For New Directors
Attachment
Exchange Announcement •
19 Jun 2024 15:04
Announcement On Behalf Of Obigen Of Re-Election Of Directors And Supervisors At The 2024 Annual General Shareholders’ Meeting
Attachment
Exchange Announcement •
19 Jun 2024 15:03
Announcement On Behalf Of Obigen Of Important Resolutions Of 2024 Annual Shareholders’ Meeting And Accumulated Losses Amounting To 50% Of Paid-In Capital
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x